Priscilla Agbenyefia, MD
Pain Medicine · Peachtree Corners, GANPI 1851786420
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Spinal Simplicity, LLC at 24.6% of the total. Reporting peaked in 2021 at $3,892 and has fallen 71.9% since, to $1,094 in 2025.
Across 164 payments — averaging $52.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$2K
- Abbott$2K
- Nevro Corp.$1K
- Boston Scientific$1K
- Medtronic$639
- Globus Medical$311
- plus $1K from 23 others
What the payments were for
- Travel & lodging$1,65819%
- Food & beverage$5,09360%
- Education$1,80521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 4 | $2,106 |
| Abbott | 23 | $1,986 |
| Nevro Corp. | 28 | $1,265 |
| Boston Scientific | 43 | $1,073 |
| Medtronic | 13 | $639 |
| Globus Medical | 5 | $311 |
| Electronic Waveform Lab, Inc. | 1 | $174 |
| Braeburn Inc. | 1 | $145 |
| Indivior Inc. | 5 | $115 |
| Collegium Pharmaceutical, Inc. | 6 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $83 |
| Averitas Pharma Inc. | 3 | $76 |
| Biotronik NRO, Inc. | 3 | $69 |
| AbbVie | 3 | $62 |
| USWM, LLC | 3 | $57 |
| Nalu Medical, Inc. | 3 | $45 |
| Lilly USA, LLC | 3 | $42 |
| Pfizer | 1 | $24 |
| Vertos Medical, Inc. | 1 | $21 |
| Amgen | 1 | $21 |
| Forte Bio-pharma LLC | 1 | $20 |
| Galt Pharmaceuticals, LLC | 1 | $19 |
| Zavation Medical Products, LLC | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Relievant Medsystems, Inc. | 1 | $17 |
| Atland Pharmaceuticals, LLC | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Saluda Medical Americas, Inc. | 1 | $14 |
| SPR Therapeutics, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$2,014
- Proclaim IPG$1,061
- Senza$625
- PROCLAIM$251
- INTELLIS ADAPTIVESTIM$236
- BRIXADI$145
- Accurian$131
- Senza Spinal Cord Stimulation System$115
How this compares
$8,557 in reported general payments places this provider in the 85th percentile of 203 pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MovantikNaloxegol Oxalate | 22 | $8,990 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 282 | $7,415 |
| Buprenorphine | 23 | $6,259 |
| Xtampza ErOxycodone Myristate | 16 | $3,090 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 34 | $2,784 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 123 | $2,612 |
| Pregabalin | 145 | $1,833 |
| Lidocaine | 11 | $1,773 |
| Gabapentin | 103 | $1,103 |
| Oxycodone Hcl | 75 | $864 |
| Tizanidine Hcl | 47 | $755 |
| Duloxetine Hcl | 16 | $601 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 30 | $581 |
| Cyclobenzaprine Hcl | 38 | $408 |
| Methocarbamol | 18 | $361 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $92 | $3,09016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 203 pain medicine providers in Georgia.
Other pain medicine in Peachtree Corners
- Rutvij ShahColumbus$86K
- Siddardth UmapathyFort Eisenhower$41K
- Susheel DuaAtlanta$36K
- Subodh AgrawalAthens$34K
- Jose MathewLawrenceville$27K
- Zhuo SunAugusta$26K
- Maged HamzaGainesville$24K
- Ankur PatelGainesville$21K
- Margaret RisoGainesville$19K
- Steven HanlingAugusta$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.